Spencer Luiz Marques Payão Selected Research

Stomach Diseases

1/2019	Status (on/off) of oipA gene: their associations with gastritis and gastric cancer and geographic origins.
1/2017	Interleukin 8 (-251 T>A) polymorphism in children and teenagers infected with Helicobacter pylori.
3/2016	Downregulated Expression of E-cadherin and TP53 in Patients with Gastric Diseases: the Involvement of H. pylori Infection and Its Virulence Markers.
1/2015	Lack of association among TNF-α gene expression, -308 polymorphism (G > A) and virulence markers of Helicobacter pylori.
1/2014	Association among H. pylori virulence markers dupA, cagA and vacA in Brazilian patients.
4/2005	cagA vacA alelles and babA2 genotypes of Helicobacter pylori associated with gastric disease in Brazilian adult patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Spencer Luiz Marques Payão Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 03/2013 - 08/2004
6	Stomach Neoplasms (Stomach Cancer) 06/2021 - 05/2007
6	Stomach Diseases 01/2019 - 04/2005
3	Carcinogenesis 06/2021 - 07/2014
3	Gastritis 06/2021 - 03/2016
3	Neoplasms (Cancer) 03/2016 - 01/2011
2	Adenocarcinoma 06/2021 - 07/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 01/2011
1	Diabetes Mellitus 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Myoma 01/2021
1	Amenorrhea 01/2021
1	Infections 01/2015
1	Carcinoma (Carcinomatosis) 01/2014
1	Duodenal Ulcer (Curling's Ulcer) 01/2014
1	Genomic Instability 01/2011
1	Hematologic Neoplasms (Hematological Malignancy) 01/2011
1	Myocardial Infarction 01/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2007
1	Inflammation (Inflammations) 08/2006

Drug/Important Bio-Agent (IBA)

3	Messenger RNA (mRNA)IBA 03/2016 - 12/2012
2	MicroRNAs (MicroRNA)IBA 06/2021 - 03/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2011
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 11/2007
2	Virulence Factors (Pathogenicity Factors)IBA 01/2014 - 04/2005
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Caspase 9IBA 06/2021
1	Hormones (Hormone)IBA 01/2021
1	Decitabine FDA Link 01/2020
1	Staphylococcal Protein A (Protein A)IBA 01/2019
1	Cadherins (E-Cadherin)IBA 03/2016
1	Glycoproteins (Glycoprotein)IBA 03/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	B 823-08IBA 01/2015
1	trichostatin A (A 300)IBA 07/2014
1	theasinensin AIBA 07/2014
1	AcetyltransferasesIBA 07/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2014
1	Histones (Histone)IBA 07/2014
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 07/2014
1	Histone Deacetylase InhibitorsIBA 07/2014
1	ButyrylcholinesteraseIBA 03/2013
1	AcetylcholinesteraseIBA 03/2013
1	Sirtuin 1IBA 12/2012
1	InterleukinsIBA 06/2012
1	HeterochromatinIBA 01/2011
1	ApolipoproteinsIBA 01/2011
1	DNA Transposable Elements (Element, IS)IBA 01/2011
1	Azacitidine (5 Azacytidine)FDA Link 01/2011
1	Ribosomal DNA (rDNA)IBA 11/2008
1	Sirtuin 3IBA 03/2008
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2007
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2007
1	VLDL LipoproteinsIBA 01/2007
1	oxidized low density lipoproteinIBA 01/2007
1	LipidsIBA 01/2007
1	HDL LipoproteinsIBA 01/2007
1	Apolipoprotein A-VIBA 12/2006
1	Proteins (Proteins, Gene)FDA Link 08/2006
1	Cytotoxins (Cytolysins)IBA 04/2005
1	Apolipoproteins E (ApoE)IBA 08/2004
1	Apolipoprotein E4IBA 08/2004

Therapy/Procedure

2	Therapeutics 07/2014 - 05/2007
1	Uterine Artery Embolization 01/2021